BRND.ME, formerly Mensa Brands, has converted into a public company after shifting its corporate base to India. The consumer brands platfor...

The National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...

Two MBA graduates from Punjab's Ludhiana are making headlines for achieving a remarkable feat, cultivating premium Kashmiri saffron indoors...

The Supreme Court has overturned a Rs 202-crore penalty imposed on Amazon by the Competition Commission of India. This penalty was related ...

The Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...

With the Income Tax (I-T) department questioning the tax benefits it had claimed, the Wall Street firm is understood to be working on initi...

The National Company Law Appellate Tribunal (NCLAT) has held that the National Company Law Tribunal (NCLT) could not directly order an inve...

INOXGFL Group is poised to acquire Vena Energy's Indian renewable energy business. The deal is valued between ₹4,500-5,000 crore. This move...

Walmart-owned Flipkart has indefinitely paused its IPO plans due to rising market volatility and a crowded pipeline of upcoming public issu...

Amazon and Future Coupons Pvt Ltd have settled their long-running dispute and agreed to withdraw all legal proceedings across forums follow...

India plans to set up a special NCLT bench with trained members to handle cross-border insolvency cases once new rules under the Insolvency...

The company said it was disappointed by the decision but it was a procedural one ruling only whether Zee could pursue its application with ...

CSAPLH is Carlsberg's partner for operations in India and Nepal - which is controlled by Singapore resident C P Khetan - and has a 33.3% st...

The high court, which is hearing a plea of Daiichi seeking execution of the Rs 3,500 crore Singapore tribunal arbitral award against former...

A Singapore tribunal last year ordered the Singh brothers to pay the Japanese drug maker Rs 2,562-crore damages for concealing information.

The Singh brothers have appealed against the order in Singapore as well.Rs 3,500 crore.

The company’s statement came in the wake of a news report that said Ranbaxy’s promoters duped Japanese drugmaker Diiachi Sankyo by withhold...